MURDOCK CAPITAL PARTNERS CORP.Consulting Agreement • September 25th, 2024 • Apimeds Pharmaceuticals US, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 25th, 2024 Company IndustryPursuant to our recent conversations regarding the Think Equity capital raise and IPO Initial Public Offering - for Apimeds Pharmaceuticals US, Inc. (“Apimeds USA”) this letter is to acknowledge and confirm the terms of an advisory and corporate consulting fee agreement (the “consulting agreement”) as follows:
MURDOCK CAPITAL PARTNERS CORP.Consulting Agreement • August 5th, 2024 • Apimeds Pharmaceuticals US, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 5th, 2024 Company IndustryPursuant to our recent conversations regarding the Think Equity capital raise and IPO Initial Public Offering - for Apimeds Pharmaceuticals US, Inc. (“Apimeds USA”) this letter is to acknowledge and confirm the terms of an advisory and corporate consulting fee agreement (the “consulting agreement”) as follows:
MURDOCK CAPITAL PARTNERS CORP.Consulting Agreement • June 17th, 2024 • Apimeds Pharmaceuticals US, Inc. • Pharmaceutical preparations
Contract Type FiledJune 17th, 2024 Company IndustryPursuant to our recent conversations regarding the Think Equity capital raise and IPO Initial Public Offering - for Apimeds Pharmaceuticals US, Inc. (“Apimeds USA”) this letter is to acknowledge and confirm the terms of an advisory and corporate consulting fee agreement (the “consulting agreement”) as follows: